Evidence map›Paper›PMID 29748201›Full record

ArticleAJNR. American journal of neuroradiology2018

Quantitative Assessment of Normal Fetal Brain Myelination Using Fast Macromolecular Proton Fraction Mapping.

V L Yarnykh, I Y Prihod'ko, A A Savelov, A M Korostyshevskaya

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Diagnostic Potential of Macromolecular Proton Fraction Mapping Combined with Quantitative Susceptibility Mapping as a Subcortical Biomarker for Parkinson's Disease.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Demyelination in Patients with POST-COVID Depression.Journal of clinical medicine · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Data-Driven Retrospective Correction of BIEEE transactions on medical imaging · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

V L YarnykhFrom the Department of Radiology (V.L.Y.), University of Washington, Seattle, Washington yarnykh@uw.edu.ORCID 0000-0002-1583-8979
I Y Prihod'koInstitute "International Tomography Center" of the Siberian Branch of the Russian Academy of Sciences (I.Y.P., A.A.S., A.M.K.), Novosibirsk, Russian Federation.ORCID 0000-0002-3321-7164
A A SavelovInstitute "International Tomography Center" of the Siberian Branch of the Russian Academy of Sciences (I.Y.P., A.A.S., A.M.K.), Novosibirsk, Russian Federation.ORCID 0000-0002-5332-2607
A M KorostyshevskayaInstitute "International Tomography Center" of the Siberian Branch of the Russian Academy of Sciences (I.Y.P., A.A.S., A.M.K.), Novosibirsk, Russian Federation.ORCID 0000-0002-0095-8994
International Tomography Center · RUNational Research Tomsk State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeFast macromolecular proton fraction mapping is a recently emerged MRI method for quantitative myelin imaging. Our aim was to develop a clinically targeted technique for macromolecular proton fraction mapping of the fetal brain and test its capability to characterize normal prenatal myelination. MATERIALS AND

methodsThis prospective study included 41 pregnant women (gestational age range, 18-38 weeks) without abnormal findings on fetal brain MR imaging performed for clinical indications. A fast fetal brain macromolecular proton fraction mapping protocol was implemented on a clinical 1.5T MR imaging scanner without software modifications and was performed after a clinical examination with an additional scan time of <5 minutes. 3D macromolecular proton fraction maps were reconstructed from magnetization transfer-weighted, T1-weighted, and proton density-weighted images by the single-point method. Mean macromolecular proton fraction in the brain stem, cerebellum, and thalamus and frontal, temporal, and occipital WM was compared between structures and pregnancy trimesters using analysis of variance. Gestational age dependence of the macromolecular proton fraction was assessed using the Pearson correlation coefficient (

resultsThe mean macromolecular proton fraction in the fetal brain structures varied between 2.3% and 4.3%, being 5-fold lower than macromolecular proton fraction in adult WM. The macromolecular proton fraction in the third trimester was higher compared with the second trimester in the brain stem, cerebellum, and thalamus. The highest macromolecular proton fraction was observed in the brain stem, followed by the thalamus, cerebellum, and cerebral WM. The macromolecular proton fraction in the brain stem, cerebellum, and thalamus strongly correlated with gestational age (

conclusionsMyelin is the main factor determining macromolecular proton fraction in brain tissues. Macromolecular proton fraction mapping is sensitive to the earliest stages of the fetal brain myelination and can be implemented in a clinical setting.

Indexed as

Myelin SheathAdultBrainBrain MappingCross-Sectional StudiesFemaleFetusGestational AgeHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingPregnancyPregnancy Trimester, SecondPregnancy Trimester, ThirdProspective StudiesProtonsProtons

Identifiers

PMID29748201
PMCPMC7655450
OpenAlexW2802925657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.